These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7256183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB, Beeuwkes R.
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM, Zenser TV, Ciarochi FF, Davis BB, Robinson AG.
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [Abstract] [Full Text] [Related]

  • 8. Failure of infusion of prostaglandin A2 to restore the response to antidiuretic hormone in rats with polyuria induced by lithium.
    Christensen S.
    J Endocrinol; 1980 Mar; 84(3):459-65. PubMed ID: 7391718
    [Abstract] [Full Text] [Related]

  • 9. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK.
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased urinary excretion of PGE2 during inappropriate antidiuresis induced by DDAVP.
    Craven PA, Verbalis JG, DeRubertis FR.
    Kidney Int; 1986 Jun; 29(6):1110-5. PubMed ID: 3462422
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor antagonizes vasopressin in vivo and in vitro.
    Phillips PA, Grant SL, Davidson AF, Risvanis J, Stephenson J, Gow CB.
    Kidney Int; 1994 Apr; 45(4):1028-36. PubMed ID: 8007572
    [Abstract] [Full Text] [Related]

  • 13. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M, Vilhardt H.
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
    Hunsballe JM, Hansen TK, Rittig S, Pedersen EB, Djurhuus JC.
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
    [Abstract] [Full Text] [Related]

  • 16. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K, Kimura T, Ota K, Iitake K, Shoji M, Inoue M, Yoshinaga K.
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DDAVP-induced maternal hyposmolality increases ovine fetal urine flow.
    Nijland MJ, Ross MG, Kullama LK, Bradley K, Ervin MG.
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R358-65. PubMed ID: 7864229
    [Abstract] [Full Text] [Related]

  • 19. Assessment of renal concentrating ability.
    Curtis JR, Donovan BA.
    Br Med J; 1979 Feb 03; 1(6159):304-5. PubMed ID: 421089
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.